Evaluation of Anti-Xa Target Attainment with Prophylactic Enoxaparin Dosing Regimens for Venous Thromboembolism Prophylaxis in Morbidly Obese Patients

• Main Authors: Andrew Sabers (Author), Emilie Langenhan (Author), Sean N. Avedissian (Author), Brandon Reynolds (Author)
• Formato: Libro
• Publicado: MDPI AG, 2024-08-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Subcutaneous enoxaparin has been shown to reduce the risk of venous thromboembolism (VTE) among hospitalized patients. However, alternative enoxaparin dosing strategies may be necessary in morbid obesity. The objective of this study was to assess the rate of target anti-Xa attainment with three enox...